Search research articles
Contact Us
Filters
Showing results (511-520 of 674) with videos related to
Page
of 68
Sort By:
Analytical Chemistry
|
February 19, 2021
Method to Investigate the Distribution of Water-Soluble Drug-Delivery Systems in Fresh Frozen Tissues Using Imaging Mass Cytometry
Nicole Strittmatter, Richard M England, Alan M Race, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 27, 2023
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence
Nikita Sushentsev, Gregory Hamm, Jack Richings, et al.
Cancer Discovery
|
November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
Manish Neupane, Allison P Clark, Serena Landini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations
Ursula Grazini, Aleksandra Markovets, Lucy Ireland, et al.
JNCI Cancer Spectrum
|
May 13, 2021
Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)
Jennifer A Ligibel, Luke Huebner, Hope S Rugo, et al.
The Journal of Clinical Investigation
|
February 18, 2015
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Luke Boulter, Rachel V Guest, Timothy J Kendall, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2019
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
Molly A Taylor, Adina M Hughes, Josephine Walton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2020
Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
O Metzger Filho, J P Leone, T Li, et al.
Plos One
|
February 2, 2026
The association between long-term opioid therapy and composite infection-related dental outcomes
Anne C Black, Kirsha S Gordon, James D Dziura, et al.
Molecular Cancer Therapeutics
|
February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer
Mickey K Kim, Takuya Osada, William T Barry, et al.
Page
of 68
Search research articles
Search
Showing results (511-520 of 674) with videos related to
Sort By:
Page
of 68
Analytical Chemistry
|
February 19, 2021
Method to Investigate the Distribution of Water-Soluble Drug-Delivery Systems in Fresh Frozen Tissues Using Imaging Mass Cytometry
Nicole Strittmatter, Richard M England, Alan M Race, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 27, 2023
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence
Nikita Sushentsev, Gregory Hamm, Jack Richings, et al.
Cancer Discovery
|
November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
Manish Neupane, Allison P Clark, Serena Landini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations
Ursula Grazini, Aleksandra Markovets, Lucy Ireland, et al.
JNCI Cancer Spectrum
|
May 13, 2021
Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)
Jennifer A Ligibel, Luke Huebner, Hope S Rugo, et al.
The Journal of Clinical Investigation
|
February 18, 2015
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Luke Boulter, Rachel V Guest, Timothy J Kendall, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2019
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
Molly A Taylor, Adina M Hughes, Josephine Walton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2020
Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
O Metzger Filho, J P Leone, T Li, et al.
Plos One
|
February 2, 2026
The association between long-term opioid therapy and composite infection-related dental outcomes
Anne C Black, Kirsha S Gordon, James D Dziura, et al.
Molecular Cancer Therapeutics
|
February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer
Mickey K Kim, Takuya Osada, William T Barry, et al.
Page
of 68